Dogwood Therapeutics, Inc.
DWTX
$1.70
$0.010.59%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 6.10M | 9.86M | 10.34M | 9.72M | 8.70M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 27.97M | 31.70M | 18.20M | 15.34M | 12.23M |
| Operating Income | -27.97M | -31.70M | -18.20M | -15.34M | -12.23M |
| Income Before Tax | -34.04M | -38.02M | -24.55M | -21.79M | -12.35M |
| Income Tax Expenses | 221.00K | 188.70K | 190.10K | 190.00K | -500.00 |
| Earnings from Continuing Operations | -34.26 | -38.20 | -24.74 | -21.98 | -12.35 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -34.26M | -38.20M | -24.74M | -21.98M | -12.35M |
| EBIT | -27.97M | -31.70M | -18.20M | -15.34M | -12.23M |
| EBITDA | -27.93M | -31.67M | -15.86M | -11.95M | -7.54M |
| EPS Basic | -18.91 | -24.93 | -18.79 | -17.94 | -11.17 |
| Normalized Basic EPS | -8.53 | -12.05 | -8.21 | -7.68 | -6.73 |
| EPS Diluted | -18.91 | -24.93 | -18.79 | -17.94 | -11.17 |
| Normalized Diluted EPS | -8.53 | -12.05 | -8.21 | -7.68 | -6.73 |
| Average Basic Shares Outstanding | 19.79M | 6.58M | 5.77M | 4.78M | 4.11M |
| Average Diluted Shares Outstanding | 19.79M | 6.58M | 5.77M | 4.78M | 4.11M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |